Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01071226 · ClinicalTrials.gov registry record · NA

Peripheral Blood Stem Cell Transplantation Using the CliniMACS Device

A NA study, sponsored by Medical College of Wisconsin.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT01071226: Completed NA study, sponsored by Medical College of Wisconsin.

NCT01071226 is a NA study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01071226, a NA study, has completed, sponsored by Medical College of Wisconsin.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

T cell depletion utilizing the CliniMACS device will allow more precise, specific and controlled graft engineering of peripheral blood stem cells from unrelated and partially matched related donors without an increase in relapse or graft rejection and grade III or IV acute graft versus host disease (GVHD).

Interventions

  • DEVICE CliniMACS (CD+3, CD+19 depletion)
  • DEVICE CliniMACS (CD 34+ positive selection)
  • OTHER HSCT

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2008-05
Est. Completion 2020-04-28
Phase NA
Medical College of Wisconsin

447 total trials

What the finished NCT01071226 record still lists

NCT01071226 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 3 interventions - of which CliniMACS (CD+3, CD+19 depletion) is the first listed.

NCT01071226 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01071226 about?

NCT01071226 is a clinical study titled "Peripheral Blood Stem Cell Transplantation Using the CliniMACS Device". T cell depletion utilizing the CliniMACS device will allow more precise, specific and controlled graft engineering of peripheral blood stem cells from unrelated and partially matched related donors without an increase in relapse or graft rejection and grade III or IV acute graft versus host disease ...

What is the current status of trial NCT01071226?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2008-05. Estimated completion is 2020-04-28.

What interventions are being tested in trial NCT01071226?

The interventions under investigation include: CliniMACS (CD+3, CD+19 depletion) (DEVICE), CliniMACS (CD 34+ positive selection) (DEVICE), HSCT (OTHER).

Who is sponsoring clinical trial NCT01071226?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01071226's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01071226, the US trial registry maintained by the National Library of Medicine. NCT01071226 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.